CMG Pharmaceutical is engaged in the research and development of disease-related single nucleotide polymorphism (SNP) contents using SNP. These diseases include asthma, diabetes, osteoporosis, alcoholism, tuberculosis, cancer, multiple sclerosis, obesity, mental illness, metabolic disease, lupus disease.
CMG Pharmaceutical Co., Ltd
Category:
Large
Main Business Area
Disease-related single nucleotide polymorphism (SNP) contents
| Contact Details | (13488) CHA Bio Complex, 335 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-doTel. 031-881-7600 |
|---|
